Russell Investments Group’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
429,673
+63,407
+17% +$334K ﹤0.01% 2020
2026
Q1
$1.53M Buy
366,266
+5,514
+2% +$26.5K ﹤0.01% 2004
2025
Q4
$1.74M Sell
360,752
-13,421
-4% -$64.9K ﹤0.01% 1953
2025
Q3
$1.89M Sell
374,173
-191,913
-34% -$848K ﹤0.01% 1891
2025
Q2
$2.28M Sell
566,086
-103,489
-15% -$337K ﹤0.01% 1662
2025
Q1
$1.83M Buy
669,575
+103,170
+18% +$370K ﹤0.01% 1754
2024
Q4
$2.41M Buy
566,405
+338,103
+148% +$1.29M ﹤0.01% 1580
2024
Q3
$671K Buy
228,302
+223,197
+4,372% +$710K ﹤0.01% 2176
2024
Q2
$17.8K Buy
+5,105
New +$17K ﹤0.01% 2962

Other funds holding SRTA

Russell Investments Group's SRTA Position: Q2 2026 in Review

Russell Investments Group increased its Strata Critical Medical Inc (SRTA) stake by 17% in Q2 2026, buying an estimated $334K and bringing the position to 429,673 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2020.

Russell Investments Group first reported a position in SRTA in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.41M in Q4 2024. 50 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Russell Investments Group held 429,673 shares of Strata Critical Medical Inc worth $2.26M as of Q2 2026.
  • Russell Investments Group bought 63,407 Strata Critical Medical Inc shares in Q2 2026, an estimated $334K.
  • Strata Critical Medical Inc made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2020 holding.
  • Russell Investments Group first reported a position in Strata Critical Medical Inc in Q2 2024 and has held it in 9 quarters since.
  • Russell Investments Group's Strata Critical Medical Inc position peaked at $2.41M in Q4 2024.
  • 50 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.